Eli Lilly has announced its intention to acquire Verve Therapeutics, a biotechnology company specializing in gene-editing ...

HealthDay News — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives Lilly a potential new treatment for heart disease, The Wall ...

A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain ...

People who have frequent nightmares appear to have a tripled risk of premature death, according to a new study.